✅ What Are Biologics?
Biologics are targeted treatments made from living cells. They work by blocking parts of the immune system that cause inflammation — for example:
-
IL-4, IL-5, IL-13: linked to eosinophilic inflammation
-
IgE: linked to allergies and ABPA
They are not immunosuppressants like steroids or chemotherapy, but rather immune modulators.
💊 Long-Term Side Effects – What Do We Know?
👨⚕️ What research and experience show:
| Biologic | Used for | Long-term safety known? | Side effects most reported |
|---|---|---|---|
| Omalizumab (Xolair) | Allergic asthma, ABPA | 20+ years of use | Injection site reactions, headache, very rare anaphylaxis |
| Mepolizumab (Nucala) | Eosinophilic asthma, CPA | 10+ years | Fatigue, headache, shingles (rare), mild infections |
| Benralizumab (Fasenra) | Severe asthma, CPA | ~6–7 years | Headache, pharyngitis, injection site issues |
| Dupilumab (Dupixent) | Asthma, eczema, nasal polyps | 6–8 years | Eye dryness/redness, cold sores, joint pain (rare) |
| Tezepelumab (Tezspire) | Severe asthma | ~2 years | Sore throat, joint pain, injection site reactions |
⚠️ Possible Long-Term Concerns (but rare)
-
Infections: Some concern about slightly increased risk of herpes zoster (shingles) or respiratory viruses, but overall risk is very low compared to steroids.
-
Immunogenicity: Your body might develop antibodies to the drug over time, reducing its effect — this is more a loss of benefit, not a dangerous side effect.
-
Cancer risk: No consistent evidence linking asthma/ABPA biologics to cancer.
-
Unknowns: Because some biologics are new (e.g. tezepelumab), we don’t yet have 20-year data — but so far the safety profile is reassuring.
🩺 Compared to Oral Steroids
| Treatment | Side Effects Over Time |
|---|---|
| Steroids (e.g. prednisolone) | Weight gain, diabetes, infections, bone thinning, cataracts, adrenal suppression |
| Biologics | Mostly minor – injection site pain, headache, mild infection risk, rare allergic reaction |
So in most cases, biologics reduce the need for steroids and therefore reduce long-term harm.
💬 Patient Experience
Most patients report:
-
Improved quality of life
-
Reduced asthma/ABPA attacks
-
Fewer hospital visits
-
Very few stop due to side effects
✅ Summary
| Question | Answer |
|---|---|
| Do biologics have long-term side effects? | Usually mild and rare; mostly injection reactions or mild infections |
| Are they safer than long-term steroids? | Yes, especially over years |
| Should I be worried? | Not usually — but always monitor with your team |
| How long have they been used? | 6–20+ years, depending on the biologic, with very good safety data |
Share this post
Latest News posts
🔬 Charcot–Leyden Crystals in ABPA and Asthma
February 13, 2026
Event: 📸 Science is Open: A Photo Journey of Research Lab Samples
February 12, 2026
How to Join Our Microsoft Teams Meetings – Troubleshooting
February 12, 2026
Health effects: why aspergillosis patients are higher-risk
February 10, 2026
Damp, mould and aspergillosis in rented homes (UK)
February 10, 2026
Recognising a damp or mouldy home
February 10, 2026
Your rights, the law, and UK support organisations
February 10, 2026
Remediation, verification, and refusal to move you
February 10, 2026
How to raise damp and mould with your landlord (and get action)
February 10, 2026
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
